Speaker Presentations - Day One

From Evidence to Policy to Practice

Monday, April 3, 2006

Processes and mechanisms for contextualizing scientific evidence – Moving from HTA to HTPA?

• Véronique Déry, Chief Executive Officer and Scientific Director, AETMIS
  

Field Evaluations for Reducing Uncertainty in Decision Making: What are They, How can they be Used and are They Useful?

• Ron Goeree, Jim Bowen, Jean-Eric Tarride, Gord Blackhouse, Daria O’Reilly, Rob Hopkins

What is evidence?

• Chris McCutcheon, Senior Program Officer, Canadian Health Services Research Foundation

The Use of Recommendations in Decision Making: A Multi-Dimensional Perspective

• Dr Marie-Pierre Gagnon, Université Laval

Linking Evidence & Policy: The Alberta Model

• Henry Borowski, Director, Health Technologies & Services Policy, Alberta Health and Wellness

The Health Technology Inquiry Service (HTIS): Providing Information for Canadian Health Care Decision Makers

• Kirsten Garces, Manager CETAP/HTIS – Pharmaceuticals, CADTH

Enhancing HTA Use in Low-Resource Jurisdictions

• Dr. Stephen Bornstein, Director, Newfoundland and Labrador Centre for Applied Health Research
• Sheila Tucker, CADTH Liaison Officer for Newfoundland & Labrador

Expensive Drugs for Rare Diseases: Experience at the decision making Front

• Dr. Janet Martin, Director, High Impact Technology Evaluation Centre, London Health Sciences Centre

Drug class reviews and formulary management: a survey of Canadian jurisdictions

• Michel Boucher, Research Officer, CADTH

PHAC / CACDS Point-Of-Sale (Pos) Data Sharing Initiative

• Allan Malek, Vice President, Pharmacy, Canadian Association of Chain Drug Stores
• Victoria L. Edge, BSc., MSc., PhD Candidate, Epidemiologist Foodborne, Waterborne & Zoonotic Infections Division, Public Health Agency of Canada

Pharmaceutical Benefit Plans for Children: Using Evidence to Improve Outcomes

• Dr. Wendy Ungar, Scientist, Hospital for Sick Children

Synthesizing evidence on the front line: Can it work?

• Sarah Hayward, CEO, SEARCH Canada

Regional Clinical Pathways are successful in improving the health care system for Total Joint Replacements

• Rhona McGlasson, Total Joint Network

Trial Registration as a Tool to Achieve Higher Quality and Availability of Evidence in Health: Canadian Institutes of Health Research (CIHR) and Global Perspective

• Dr. Karmela Krleza-Jeric, CIHR

Parameters of Success in Decision Making

• Shannon Madden, University of Toronto

Litigating Access to Health Care Services in Canada: The Role of HTA in the Courtroom

• Nola Ries, Research Associate, Health Law Institute, University of Alberta

Implicit Health Technology Assessment: A Descriptive Study of Ontario Appeal Board Cases

• Mita Giacomini, McMaster University

Cumulative Meta-Analysis to Determine Key Milestones in the Life Cycle of Evidence in Cancer Care

• Dr. Neil Reaume, Ottawa Health Research Institute/The Ottawa Hospital Regional Cancer Centre

Hospital HTPA: Mandate or Wishful Thinking?

• Dr. Janet Martin, Director, High Impact Technology Evaluation Centre, London Health Sciences Centre

Interventions to Promote Information and Communication Technologies Adoption in Health Care: A 'Realist' Systematic Review

• Dr. Marie-Pierre Gagnon, Université Laval

Clinical Technology/Therapy Assessment: An approach to technology/therapy adoption at Massachusetts General Hospital.

• Arjun C. Rao, Senior Project Specialist, Clinical Technology Assessment and Innovation Decision Support and Quality Management Unit, Massachusetts General Hospital

Evidence-based recommendations – Is it “just evidence” or “beyond evidence”?

• Karen Lee, Health Economist, CDR, CADTH (Convenor)

Panelists:

• Dr. Andreas Laupacis, President and CEO, Institute for Clinical Evaluative Sciences
• Dr. Terri O’Grady, Clinical Reviewer, Common Drug Review Director, CADTH
• Dr. Reiner Banken, Deputy Chief Executive Officer, Development and Partnerships, AETMIS
• Bob Nakagawa, Assistant Deputy Minister, Pharmacare, BC Ministry of Health

Translating Systematic Review Evidence for Patient Decision Making According to International Standards

• Dr. Dawn Stacey, Assistant Professor, School of Nursing, University of Ottawa

Consumer Involvement in Decision Making for Health Care Policy and Planning

• Nancy Santesso, Knowledge Translation Specialist, Cochrane Musculosketetal Group
• Anne Dooley, President, Canadian Arthritis Patient Alliance

Linking the public in priority-setting for HTA: Findings from a citizen’s jury

• Tania Stafinski, University of Alberta
• Dr. Devidas Menon, Professor Health Policy and Management Program, University of Alberta